Page 2 - ஜோசப் தோம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜோசப் தோம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜோசப் தோம் Today - Breaking & Trending Today

United Therapeutics Corp (UTHR) Q4 2020 Earnings Call Transcript

Operator
Good morning, and welcome to the United Therapeutics Corporation Fourth Quarter 2020 Earnings Call. My name is Kenzie, and I will be your conference operator today. [Operator Instructions]
I will now turn the conference call over to Mr. Dewey Steadman, Head of Investor Relations at United Therapeutics.
Dewey Steadman
Head of Investor Relations
Good morning. It s my pleasure to welcome you to the United Therapeutics Corporation Fourth Quarter 2020 Earnings Call. Accompanying me on today s call are Dr. Martine Rothblatt, our Chairman and Chief Executive Officer; Mr. Michael Benkowitz, our President and Chief Operating Officer; Mr. James Edgemond, our Chief Financial Officer and Treasurer; and Dr. Leigh Peterson, Vice President of Product Development. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events. These statements involve risks and uncertainties that may cause actual results to di ....

New York , United States , Hartaj Singh , Hartaj Singh Oppenheimer , Mike Benkowitz , Terence Flynn Goldman Sachs , Jessica Fye , Leigh Peterson , Joseph Thome Cowen , Joseph Thome , Eun Yang Jefferies , Michael Benkowitz , Terence Flynn , James Edgemond , Jessica Fye Jpmorgan , Subcu Remodulin , Marty Auster , Dewey Steadman , Martine Rothblatt , Eun Yang , United Therapeutics Corporation , United Therapeutics Corp , Goldman Sachs , Credit Suisse , Product Development , United Therapeutics Corporation Fourth Quarter ,

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript

Esperion Therapeutics Inc (ESPR) Q4 2020 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Esperion Therapeutics Inc (NASDAQ: ESPR)
Popular Searches
Operator
Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today s conference call may be recorded. I would now like to hand the conference call over to Ben Church, Investor Relations and Corporate Communications at Esperion. Please go ahead, sir.
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company s SEC fili ....

Rick Bartram , Daiichi Sankyo Europe , Sheldon Koenig , Derek Archila , Julian Harrison , Joseph Thome Cowen , Joseph Thome , Michael Yee , Richard Bartram , Tim Mayleben , Geoff Meacham , Olivia Brayer , America Merrill Lynch , Timothy Mayleben , Daiichi Sankyo , Martin Auster , Tom Shrader , Michael Yee Jefferies , Paul Choi , Company Update Conference Call , Esperion Therapeutics Inc , Goldman Sachs , Credit Suisse , Ben Church , Corporate Communications Investor Relations , Motley Fool Esperion Therapeutics Inc ,